DONNELLY v. KERYX BIOPHARMACEUTICALS, INC.

C.A. No. 2018-0892-SG.

MICHAEL J. DONNELLY, Plaintiff, v. KERYX BIOPHARMACEUTICALS, INC., Defendant.

Court of Chancery of Delaware.

Decided: October 24, 2019.


Attorney(s) appearing for the Case

Peter B. Andrews , Craig J. Springer , and David M. Sborz , of ANDREWS & SPRINGER LLC, Wilmington, Delaware; OF COUNSEL: Randall J. Baron , David T. Wissbroecker , and Christopher H. Lyons , of ROBBINS GELLER RUDMAN & DOWD LLP, San Diego, California and Nashville, Tennessee, Attorneys for Plaintiff.

David E. Ross and S. Michael Sirkin , of ROSS ARONSTAM & MORITZ LLP, Wilmington, Delaware; OF COUNSEL: Peter L. Welsh , Christian Reigstad , and Mary Zou , of ROPES & GRAY LLP, New York, New York, Attorneys for Defendant.


MEMORANDUM OPINION

What follows is, for me at least, a rare bird; a written Section 220 decision. This Memorandum Opinion addresses Plaintiff's Section 220 demand for books and records from Keryx Biopharmaceuticals, Inc. ("Defendant" or "Keryx") related to its 2018 merger with Akebia Therapeutics...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases